Works matching AU Lee, Yong‐ho


Results: 172
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes (TRIPLE‐AXEL study): A multicentre, randomized, 104‐week, open‐label, active‐controlled trial

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3642, doi. 10.1111/dom.15705
    By:
    • Kim, Nam Hoon;
    • Moon, Jun Sung;
    • Lee, Yong‐ho;
    • Cho, Ho Chan;
    • Kwak, Soo Heon;
    • Lim, Soo;
    • Moon, Min Kyong;
    • Kim, Dong‐Lim;
    • Kim, Tae Ho;
    • Ko, Eunvin;
    • Lee, Juneyoung;
    • Kim, Sin Gon
    Publication type:
    Article
    25
    26

    Moderate‐intensity statin with ezetimibe combination therapy versus high‐intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post‐hoc analysis of the RACING trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 829, doi. 10.1111/dom.15374
    By:
    • Lee, Yong‐Joon;
    • Lee, Sang‐Hyup;
    • You, Seng Chan;
    • Lee, Yong‐ho;
    • Lee, Seung‐Jun;
    • Hong, Sung‐Jin;
    • Ahn, Chul‐Min;
    • Kim, Byeong‐Keuk;
    • Ko, Young‐Guk;
    • Choi, Donghoon;
    • Hong, Myeong‐Ki;
    • Jang, Yangsoo;
    • Kim, Jung‐Sun
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    <i>Transthyretin</i> Is a Key Regulator of Myoblast Differentiation

    Published in:
    PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063627
    By:
    • Lee, Eun Ju;
    • Bhat, Abdul R.;
    • Kamli, Majid Rasool;
    • Pokharel, Smritee;
    • Chun, Tahoon;
    • Lee, Yong-Ho;
    • Nahm, Sang-Seop;
    • Nam, Joo Hyun;
    • Hong, Seong Koo;
    • Yang, Bohsuk;
    • Chung, Ki Young;
    • Kim, Sang Hoon;
    • Choi, Inho
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction‐associated fatty liver disease.

    Published in:
    Clinical & Translational Medicine, 2024, v. 14, n. 10, p. 1, doi. 10.1002/ctm2.1816
    By:
    • Lee, Minji;
    • Son, Myung Jin;
    • Hong, Sin‐Hyoung;
    • Ryu, Jae‐Sung;
    • Min, Ji‐Hyeon;
    • Lee, Dong‐Eon;
    • Lee, Ji Hoon;
    • Kim, Nam Doo;
    • Park, Shi‐Young;
    • Kim, Darong;
    • Joo, Jeongmin;
    • Kwak, Jisung;
    • Kim, Kook Hwan;
    • Lee, Yong‐Ho;
    • Keum, Byeong‐Rak;
    • Song, Hyun Seok;
    • Jung, Youngae;
    • Kim, Koon Soon;
    • Kim, Gun‐Hwa
    Publication type:
    Article
    47
    48
    49
    50